Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 18 Dec 2024

Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes

in Renal Pharmacology

Zou Zhi-yu
Dai Lin-rui
Yu Chen-zhen
Chen Ren-jie
Yu Fei-hong
Chen Song
Chang Sheng
Zhang Wei-jie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493166

445 views

Original Research

Published on 18 Dec 2024

PM2.5-induced oxidative stress upregulates PLA2R expression in the lung and is involved in the pathogenesis of membranous nephropathy through extracellular vesicles

in Renal Pharmacology

Wang Zhang
Jiating Chen
Ye Yuan
Jiao Luo
Zhanmei Zhou
Guobao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516111

763 views

Original Research

Published on 16 Dec 2024

Ondansetron use is associated with increased risk of acute kidney injury in ICU patients following cardiac surgery: a retrospective cohort study

in Renal Pharmacology

Feiyi Xu
Xun Gong
Wei Chen
Xiaomin Dong
Jiang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1511545

1,110 views

Original Research

Published on 12 Dec 2024

JiangyaTongluo decoction ameliorates tubulointerstitial fibrosis via regulating the SIRT1/PGC-1α/mitophagy axis in hypertensive nephropathy

in Renal Pharmacology

Yun Zhao
Qi Jia
Gaimei Hao
Lin Han
Yushan Gao
Xiaoyu Zhang
Ziming Yan
Boyang Li
Yiping Wu
Boya Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491315

1,387 views

Correction

Published on 12 Dec 2024

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

in Renal Pharmacology

Qian Huang
Rui Xiao
Jing Lu
Yao Zhang
Liang Xu
Jie Gao
Jing Sun
Haiping Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532797

307 views

Editorial

Published on 11 Dec 2024

Editorial: Novel pathophysiologic mechanisms and reno-protective pharmacotherapies in diabetic kidney disease

in Renal Pharmacology

Elias John Elenjickal
Anna T. Valson
Santosh Varughese
Lloyd Vincent
Edwin Fernando
Gopalakrishnan Natarajan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1531748

567 views

Original Research

Published on 11 Dec 2024

Hypoalbuminemia and cisplatin-induced acute kidney injury

in Renal Pharmacology

Wen-Jun Yin
Yu-Jie Huang
Qing Zhu
Xiao-Qing Lin
Hui-Ling Piao
Qian-Qian Yu
Chang-Hong Lai
Guang-Liang Zhou
Ling-Yun Zhou
Kun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510477

506 views

Systematic Review

Published on 11 Dec 2024

Safety of ACEI/ARB use in the early (<3 months) post kidney transplant period: a systematic review and meta-analysis

in Renal Pharmacology

Dahai Fu
Jin Li
Guanglan Zeng
Maozhi Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1522558

492 views

Systematic Review

Published on 06 Dec 2024

Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis

in Renal Pharmacology

Xiaoyue Cai
Guiming Wu
Yan Lin
Lichuan Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476587

858 views

Retraction

Published on 05 Dec 2024

Retraction: CXCL6 promotes renal interstitial fibrosis in diabetic nephropathy by activating JAK/STAT3 signaling pathway

in Renal Pharmacology

Frontiers Editorial Office

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530358

514 views

Original Research

Published on 04 Dec 2024

Calcium sensing receptor regulate claudin-14 via PKA-STAT3 pathway in rat model of nephrolithiasis

in Renal Pharmacology

Peiyue Luo
Tao Chen
Liying Zheng
Junrong Zou
Jun Zou
Wei Li
Qi Chen
Le Cheng
Biao Qian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477122

905 views

Review

Published on 02 Dec 2024

Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines

in Renal Pharmacology

Lijuan Liang
Youjun Mi
Shihan Zhou
Aojian Yang
Chaoyu Wei
Enlai Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403227

1,097 views

Original Research

Published on 02 Dec 2024

Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

in Renal Pharmacology

Guangzhuang Li
Sentao Xian
Xianchao Cheng
Yunhua Hou
Wenqing Jia
Yukui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1499012

1,051 views

Original Research

Published on 28 Nov 2024

Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway

in Renal Pharmacology

Saiji Liu
Yiling Cao
Qian Yuan
Yaru Xie
Yuting Zhu
Lijun Yao
Chun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510098

896 views

Systematic Review

Published on 27 Nov 2024

Efficacy and safety of glucocorticoid combined with cyclophosphamide therapy on membranous nephropathy: a systematic review and meta-analysis

in Renal Pharmacology

Chengcheng Feng
Xuexun Chen
Xiangming Wang
Min Guo
Zhentao Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480638

816 views

Systematic Review

Published on 15 Nov 2024

Focus on podocytes: diabetic kidney disease and renal fibrosis — a global bibliometric analysis (2000–2024)

in Renal Pharmacology

Dong-Yang An
Jun Tan
Yan-Dan Lu
Ze-Huai Wen
Yi-Ni Bao
Zhou-Hui Yao
Zi-Yan Chen
Ping-Ping Wang
Wei Zhou
Qiao Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1454586

1,660 views

Navigation group

Articles

Immunosuppressant nonadherence profile in kidney transplant recipients and the impact of medication adherence on transplant outcomes

PM2.5-induced oxidative stress upregulates PLA2R expression in the lung and is involved in the pathogenesis of membranous nephropathy through extracellular vesicles

Ondansetron use is associated with increased risk of acute kidney injury in ICU patients following cardiac surgery: a retrospective cohort study

JiangyaTongluo decoction ameliorates tubulointerstitial fibrosis via regulating the SIRT1/PGC-1α/mitophagy axis in hypertensive nephropathy

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling

Editorial: Novel pathophysiologic mechanisms and reno-protective pharmacotherapies in diabetic kidney disease

Hypoalbuminemia and cisplatin-induced acute kidney injury

Safety of ACEI/ARB use in the early (<3 months) post kidney transplant period: a systematic review and meta-analysis

Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis

Retraction: CXCL6 promotes renal interstitial fibrosis in diabetic nephropathy by activating JAK/STAT3 signaling pathway

Calcium sensing receptor regulate claudin-14 via PKA-STAT3 pathway in rat model of nephrolithiasis

Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines

Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation

Yishen paidu pills attenuates 5/6 nephrectomy induced kidney disease via inhibiting the PI3K/AKT/mTOR signaling pathway

Efficacy and safety of glucocorticoid combined with cyclophosphamide therapy on membranous nephropathy: a systematic review and meta-analysis

Focus on podocytes: diabetic kidney disease and renal fibrosis — a global bibliometric analysis (2000–2024)